73 related articles for article (PubMed ID: 12974145)
21. Oral combination therapy: repaglinide plus metformin for treatment of type 2 diabetes.
Raskin P
Diabetes Obes Metab; 2008 Dec; 10(12):1167-77. PubMed ID: 18494804
[TBL] [Abstract][Full Text] [Related]
22. [Could oral antidiabetic agents be useful in the management of different types of diabetes and syndromes of insulin resistance in children and adolescents?].
Otto-Buczkowska E; Nowowiejska B; Jarosz-Chobot P; Stańczyk J
Przegl Lek; 2009; 66(7):388-93. PubMed ID: 20043582
[TBL] [Abstract][Full Text] [Related]
23. Rational choice of oral antihyperglycaemic agents.
Chowdhury S; Sengupta N
J Indian Med Assoc; 2002 Mar; 100(3):174-5, 177. PubMed ID: 12408278
[TBL] [Abstract][Full Text] [Related]
24. [Metformin. Mode of action and effect of monotherapy and combination therapy on glucose metabolism in type 2 diabetes].
Christiansen AL; Madsbad S
Ugeskr Laeger; 2002 Apr; 164(15):2025-8. PubMed ID: 11985000
[TBL] [Abstract][Full Text] [Related]
25. The combination of insulin and oral hypoglycaemic drugs: a continuous challenge.
Quatraro A; Giugliano D
Diabete Metab; 1993; 19(2):219-24. PubMed ID: 8339852
[TBL] [Abstract][Full Text] [Related]
26. [Combination therapy of oral antidiabetic drugs with insulin].
Lotz N; Bachmann W
Z Gesamte Inn Med; 1993 Mar; 48(3):130-4. PubMed ID: 8475636
[TBL] [Abstract][Full Text] [Related]
27. [Clinically important effects of oral antidiabetic drug interactions].
Drzewoski J; Kopff B
Pol Merkur Lekarski; 2000 Sep; 9(51):605-7. PubMed ID: 11126985
[TBL] [Abstract][Full Text] [Related]
28. [Metformin--its regimen and effects].
Shiba T
Nihon Rinsho; 2002 Sep; 60 Suppl 9():382-8. PubMed ID: 12387022
[No Abstract] [Full Text] [Related]
29. Insulin and type 2 diabetes. Last resort or rational management?
Holmwood C; Philips P
Aust Fam Physician; 1999 May; 28(5):429-35. PubMed ID: 10376366
[TBL] [Abstract][Full Text] [Related]
30. Treating non-insulin-dependent diabetes. Oral agents or insulin?
Shlossberg AH
Can Fam Physician; 1993 Jan; 39():119-20, 123-6. PubMed ID: 8435549
[TBL] [Abstract][Full Text] [Related]
31. [Insulin sparing and metabolic control with metformin-insulin combination].
Isnard F
Journ Annu Diabetol Hotel Dieu; 1997; ():305-25. PubMed ID: 9296986
[No Abstract] [Full Text] [Related]
32. [Primary combined oral antidiabetic therapy in type-2 diabetes mellitus].
Winkler G; Baranyi E
Orv Hetil; 2002 Oct; 143(43):2441-7. PubMed ID: 12455146
[TBL] [Abstract][Full Text] [Related]
33. [Pitfalls in treatment with oral antidiabetic agents].
Perusicová J
Vnitr Lek; 1998 Jan; 44(1):30-5. PubMed ID: 9750481
[TBL] [Abstract][Full Text] [Related]
34. [Drug therapy of diabetes mellitus].
Kaneko T
Nihon Naika Gakkai Zasshi; 1993 Mar; 82(3):406-9. PubMed ID: 8315336
[No Abstract] [Full Text] [Related]
35. Management of the adult onset diabetic with sulfonylurea drug failure.
Genuth S
Endocrinol Metab Clin North Am; 1992 Jun; 21(2):351-70. PubMed ID: 1612070
[TBL] [Abstract][Full Text] [Related]
36. [Delayed sulfonylurea resistance in non-insulin-dependent diabetes mellitus].
Farkas K; Jermendy G; Somogyi A
Orv Hetil; 1997 Nov; 138(48):3031-5. PubMed ID: 9441264
[TBL] [Abstract][Full Text] [Related]
37. Clinical update on Humalog Mix25 a novel pre-mixed formulation of insulin lispro and NPL.
Herz M
Int J Clin Pract Suppl; 1999 Jul; 104():8-13; discussion 18-20. PubMed ID: 12669732
[No Abstract] [Full Text] [Related]
38. [Management of diabetes in general practice--current requirements. 2: Oral antidiabetics and insulin therapy].
Mehnert H
Fortschr Med; 1994 Apr; 112(12):163-6. PubMed ID: 8200602
[TBL] [Abstract][Full Text] [Related]
39. [Combination therapy with insulin and sulfonylurea].
Takamatsu J
Nihon Rinsho; 2002 Sep; 60 Suppl 9():442-6. PubMed ID: 12387031
[No Abstract] [Full Text] [Related]
40. [Combination therapy with sulfonylurea plus insulin in "secondary failure" of type 2 diabetes].
Lotz N
Ther Umsch; 1990 Jan; 47(1):49-54. PubMed ID: 2408182
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
